New National Poll Shows Canadians Strongly Support CETA and Upgrading Canada's Intellectual Property Regime.

OTTAWA, Sept. 13, 2011 /CNW/ - A public opinion poll released today by Rx&D shows that Canadians strongly support a Comprehensive Economic and Trade Agreement (CETA) with the European Union (EU) and upgrading Canada's Intellectual Property (IP) Regime.

Conducted in July and early August 2011 by Nanos Research, approximately 8 out of 10 Canadians were supportive or somewhat supportive of a free trade deal with the EU and less than 12% were opposed.

The poll of more than 1200 Canadians also found that support for an upgrade of our IP rules to at least match those of the EU and the United States is at roughly the same high level of support with (80.8%) supporting or somewhat supporting. Less than 11% were opposed. Over 87% of respondents also  believe that Canada should have the same or more intellectual property protections as the European Union and our other major trading partners, with less than 4% thinking IP protections should be less.

"These results demonstrate that Canadians understand the vital link between strong Intellectual property safeguards and research and innovation," said Russell Williams, President of Rx&D. "If Canada adopts an internationally competitive IP regime, it will drive the creation of innovative medicines, which are crucial for patients and for protecting our health care."

CETA and intellectual property are connected because Canada is being urged to upgrade its IP regime as part of the ongoing negotiations between Canada and the 27 countries of the European Union.

Recent trade agreements have benefitted Canada to the point that today one in five jobs depends on international trade. A joint Canada-EU study concluded that CETA will provide a $12 billion boost to the Canadian economy. Improvements in IP over the past 25 years have spurred an 800% increase in pharmaceutical research and development investment in Canada. Greater IP protection will also enable Canada to attract a greater share of the annual $100 billion invested globally in life sciences.

"A broad consensus of business, academic and research organizations from coast to coast believe CETA and stronger IP will bring substantial benefits to Canadians, and with these poll results we can see that Canadians also broadly agree," concluded Mr. Williams. "An agreement with the EU will open our doors to an economy of 500 million people and put Canada in the strong position of having favoured trading arrangements with the EU and the U.S. Now is the time to seize the opportunity."

Nanos Research conducted a national random telephone survey of 1,203 Canadians between July 25th and August 2nd, 2011. The margin of error for a survey of 1,203 Canadians is ± 2.8 percentage points 19 times out of 20.

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents 15,000 men and women working for 50 member companies and invests more than $1 billion in research and development each year to fuel Canada's knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.

SOURCE CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX

For further information:

Christine Choury
Media Relations
Telephone: 613.236.0455
E-mail: cchoury@canadapharma.org

Organization Profile

CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890